Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2625460 | 0.83 | ALDH1A1 (0.46) | ALDH1A1TP53CYP3A4TSHRACHE | |
| SCHEMBL4471413 | 0.76 | LMNA (0.33) | — | |
| SCHEMBL10167712 | 0.74 | NOS3 (0.43) | ALDH1A1TP53CYP3A4TSHRACHE | |
| SCHEMBL7054068 | 0.73 | ALDH1A1 (0.40) | ALDH1A1TP53CYP3A4TSHRACHE | |
| SCHEMBL21859229 | 0.73 | ALDH1A1 (0.40) | ALDH1A1TP53CYP3A4TSHRACHE | |
| SCHEMBL8204180 | 0.73 | ALDH1A1 (0.40) | ALDH1A1TP53CYP3A4TSHRACHE | |
| SCHEMBL3030918 | 0.73 | ALDH1A1 (0.40) | ALDH1A1TP53CYP3A4TSHRACHE | |
| SCHEMBL2717428 | 0.73 | NOS2 (0.48) | ALDH1A1TP53CYP3A4TSHRACHE | |
| SCHEMBL30445954 | 0.73 | ALDH1A1 (0.40) | ALDH1A1TP53CYP3A4TSHRACHE | |
| SCHEMBL30228949 | 0.73 | ALDH1A1 (0.40) | ALDH1A1TP53CYP3A4TSHRACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090099207-A1 | Cyclic sulfones useful as BACE inhibitors | RUEEGER HEINRICH | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099207-A1 | Cyclic sulfones useful as BACE inhibitors | BACE1, BACE2, APP | ALDH1A1 2260/4885TP53 1495/4885CYP3A4 1053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.